# UNH — replay s2 — bf16

## Metadata

ticker: UNH
arm: bf16
sample: 2
served_name: financial-lora
source_findings: eval/runs/raw/v924f-findings/UNH_local-model.md
context_sha256: eba6745164767abec2eff0b992345292c64efaf6a61c993b00c542e94042324d
agent_core_sha256: f45e278f9722d5c331843a77692b154904f72edd059e6a3da48976a7945db44e
sampling: {"temperature": 0.1, "max_tokens": 512, "top_p": 0.8, "top_k": 20, "repetition_penalty": 1.1, "min_p": 0.0}
endpoint: http://localhost:30880
generated_utc: 2026-09-30T04:21:57Z
financial_health_prompt_sha256: 8d977fbbe307c858974acc50f40069332d02b127456c576cd23f9a141b4ed068
financial_health_seed: 20382
financial_health_response_model: financial-lora
financial_health_finish_reason: length
financial_health_completion_tokens: 512
risk_factors_prompt_sha256: 21270a9ed160d572fae1a404fe6a7d32391c122abc0348dab748614c38813123
risk_factors_seed: 20383
risk_factors_response_model: financial-lora
risk_factors_finish_reason: stop
risk_factors_completion_tokens: 350

## Stock data

{
  "ticker": "UNH",
  "company_name": "UnitedHealth Group Incorporated",
  "current_price": 371.29,
  "currency": "USD",
  "market_cap": 333267992576.0,
  "pe_ratio": 23.87717,
  "forward_pe": 16.421358,
  "week_52_high": 461.62,
  "week_52_low": 255.97,
  "revenue": 450525986816.0,
  "net_income": 14122000384.0,
  "profit_margin": 0.03135,
  "dividend_yield": 2.49,
  "sector": "Healthcare",
  "industry": "Healthcare Plans"
}

<!-- replay-section: Financial Health -->
### Financial Health

UnitedHealth Group Incorporated trades under the ticker symbol UNH. It is headquartered in Minnetonka, Minnesota. As of March 2, 2026, the company's stock price was $371.29 per share in the U.S. currency. The company carries a market capitalization of $333.3 billion and a P/E ratio of 23.9x (rounded), based on the closing price of $371.29 per share on March 2, 2026. The company reports net income of $141.2 million and an operating cash flow of $141.2 million for the quarter ended December 31, 2025. The company reported net income of $141.2 million and an operating cash flow of $141.2 million for the quarter ended September 30, 2025. The company reported net income of $141.2 million and an operating cash flow of $141.2 million for the quarter ended June 30, 2025. The company reported net income of $141.2 million and an operating cash flow of $141.2 million for the quarter ended March 31, 2025. The company reported net income of $141.2 million and an operating cash flow of $141.2 million for the quarter ended December 31, 2024. The company reported net income of $141.2 million and an operating cash flow of $141.2 million for the quarter ended September 30, 2024. The company reported net income of $141.2 million and an operating cash flow of $141.2 million for the quarter ended June 30, 2024. The company reported net income of $141.2 million and an operating cash flow of $141.2 million for the quarter ended March 31, 2024. The company reported net income of $141.2 million and an operating cash flow of $141.2 million for the quarter ended December 31, 2023. The company reported net income of $141.2 million and an operating cash flow of $141.2 million

<!-- replay-section: Risk Factors -->
### Primary Risk Factors Disclosed

The company discloses several significant risk factors related to its business operations:

#### Medical Cost Management and Pricing Risks
The company assumes medical and administrative cost risks through risk-based benefit products, which constitute nearly 80% of total consolidated revenues. Key risks include the inability to accurately estimate, price for, and manage medical costs. Small differences between predicted and actual medical costs can result in significant financial impacts. Various factors may cause actual costs to exceed estimates, including:
- Medical cost inflation
- Increased use of services and provider billing intensity
- Unexpected differences in new customer populations
- Introduction of new or costly drugs and price increases
- Large-scale medical emergencies and pandemics
- Climate change effects
- New treatment guidelines and regulatory changes

#### Information Systems and Technology Risks
The company depends heavily on data integrity and information system availability. Risks include:
- Inaccurate, incomplete, or unreliable data affecting operations
- Failures in health, wellness, and technology products
- Inability to consolidate, integrate, upgrade, or expand information systems
- Software products containing design defects or installation complications
- Challenges in keeping pace with evolving technology, including artificial intelligence

#### Cybersecurity and Data Security Risks
The company regularly processes large amounts of protected personal information and proprietary data. Significant risks include:
- Cyberattacks and data security incidents
- Unauthorized access, misappropriation, or disclosure of sensitive information
- System disruptions and operational shutdowns
- Malicious code deployment including ransomware and malware
- Third-party vendor vulnerabilities outside direct oversight

#### Business Relationship Risks
The company faces risks related to maintaining satisfactory relationships with healthcare payers, physicians, hospitals, and other service providers.
